The FY2027 inpatient payment rule is live. Here’s what it asks of leaders.

Oct05

Posted by Greg Wahlstrom, MBA, HCM
Posted in Blog, Strategy, Finance & Policy

A 2.3% update arrived on October 1, along with new quality measures and a mandatory joint-replacement model on the horizon.

The federal fiscal year turned over last Thursday, and with it the FY2027 Inpatient Prospective Payment System final rule took effect. CMS released the rule on July 31. For most acute care hospitals, the headline is a net 2.3% payment update: a 3.2% market basket increase, reduced by a 0.9 percentage point productivity adjustment. CMS estimates the change adds roughly $2.1 billion to inpatient payments.

For many organizations, 2.3% will not keep pace with what they are paying for labor, drugs and supplies. That gap is the real story for finance and operating leaders.

What changed beyond the rate

New technology add-on payments are projected at about $779 million. Service lines that adopt qualifying new technologies should make sure the add-on is being captured.
New quality measures include Excess Days in Acute Care for diabetes, an electronic measure for postoperative venous thromboembolism, and an electronic measure for advance care planning.
A sepsis readmission measure begins with two years of confidential reporting. That gives hospitals time to see their numbers before the public does.
Medicare Advantage patients will be added to five mortality measures starting in FY2028. That will change the population behind your publicly reported results.
Long-term care hospitals receive the same 2.3% update, about $54 million in total.

The one to put on the board calendar

The rule finalizes CJR-X, a nationwide, mandatory bundled-payment model for lower-extremity joint replacement, starting January 1, 2028. Fifteen months sounds like plenty of time. It isn’t, if you still need to build post-acute partnerships, standardize care pathways and set up the data feeds to track episode spending.

Executive takeaway: Treat this year's update as a floor, not a plan. Model FY2027 margins with a 2.3% rate. Assign an owner to each new measure. Start CJR-X readiness work this quarter, while there is still time to shape how your orthopedic program responds.